Inhibitor Therapeutics (INTI) News Today → Buy this small stock before coming AI Tidal Wave (From Chaikin Analytics) (Ad) Free INTI Stock Alerts $0.09 0.00 (0.00%) (As of 05/31/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative May 29, 2024 | seekingalpha.comActuate Therapeutics Seeks IPO For Promising Pancreatic Cancer DrugsMay 23, 2024 | businesswire.comNimbus Therapeutics Presents New Positive Monotherapy Phase 1/2 Clinical Data of HPK1 Inhibitor in Treatment of Advanced Solid Tumors at 2024 ASCO Annual MeetingMay 13, 2024 | tmcnet.comMC2 Therapeutics Receives Positive Feedback from FDA pre-IND Meeting and Updates on Indication Expansion StrategyApril 30, 2024 | seekingalpha.comGTHX G1 Therapeutics, Inc.April 24, 2024 | finance.yahoo.comHDAC Inhibitor Market to Observe Stunning Growth During the Study Period (2020–2034) | DelveInsightApril 22, 2024 | finance.yahoo.comEGFR Inhibitor Market to Accelerate Substantially During the Study Period (2020–2034) | DelveInsightApril 15, 2024 | finance.yahoo.comCyclin-Dependent Kinase 9 (CDK9) Inhibitor Pipeline Research Report 2024: Drugs in Development, Therapeutics Scenario and Growth ProspectsApril 8, 2024 | msn.comSaruparib demonstrates early efficacy in breast cancers with DNA repair defects in Phase I/II trialApril 3, 2024 | finance.yahoo.comWatchmaker Genomics Announces Launch of Cost-effective RNase Inhibitor for Single-cell, Single-nuclei, and Pathogen Detection ApplicationsMarch 14, 2024 | finance.yahoo.comJanus Kinase (JAK) Inhibitor Market Forecast 2024-2034: Analyzes Trends Likely to Shape Future OpportunitiesMarch 14, 2024 | finance.yahoo.comExploring the FcRn Inhibitor Market Landscape, 2024: Market Insights, Pipeline Analysis, Expert Perspectives, and Future Trends to 2034January 10, 2024 | seekingalpha.comiTeos: Readouts From TIGIT And Adenosine Pathway Inhibitors Makes This A Must WatchJanuary 10, 2024 | tmcnet.comVYNE Therapeutics Announces Positive Biomarker Data from Successful Phase 1b Trial of VYN201 for the Treatment of VitiligoDecember 19, 2023 | finance.yahoo.comIntroducing Inhibitor Therapeutics, Inc. New Scientific Advisory BoardDecember 13, 2023 | finance.yahoo.comInhibitor Therapeutics, Inc. Exclusive License with Johns Hopkins UniversityDecember 4, 2023 | tmcnet.comInhibikase Therapeutics Granted Pre-NDA Meeting with the FDA for IkT-001ProNovember 14, 2023 | markets.businessinsider.comInhibikase Therapeutics Reports Third Quarter Financial Results and Highlights Recent Period ActivityNovember 7, 2023 | finance.yahoo.comCardurion Pharmaceuticals to Provide Update on CaMKII Inhibitor Program at the American Heart Association’s Scientific Sessions 2023October 16, 2023 | businesswire.comAntiverse and GlobalBio, Inc. Extend Collaboration to Advance Antibody Cancer TherapeuticsSeptember 5, 2023 | benzinga.comNykode Therapeutics Announces FDA Approval of IND for VB-C-04, a Trial of VB10.16 in HPV16-Positive Cervical CancerMay 18, 2023 | finanznachrichten.deTrueline Therapeutics Inc.: Trueline Therapeutics Announces Completion of IND-Enabling Studies for MCL1 Inhibitor TTX-810May 18, 2023 | businesswire.comTrueline Therapeutics Announces Completion of IND-Enabling Studies for MCL1 Inhibitor TTX-810May 17, 2023 | marketwatch.comCorrosion Inhibitor for Oil and Gas Market | Worldwide Industry Trends 2023-2030May 17, 2023 | marketwatch.comWax Inhibitor Market 2023 Fastest Growing Industry in Advanced Material Market by 2030April 20, 2023 | wsj.comInhibitor Therapeutics Inc.April 4, 2023 | msn.comOncternal Therapeutics Announces Strategic Reprioritization, Stops Two Zilovertamab StudiesApril 4, 2023 | uk.finance.yahoo.comiOmx Therapeutics Announces Dosing of First Patient with SIK Inhibitor OMX-0407 in Phase I Clinical TrialMarch 31, 2023 | marketwatch.com2023-2029 Medical FLT3 Inhibitor Market Share and Growth Insights | Latest Research ReportMarch 25, 2023 | marketwatch.comNorepinephrine Reuptake Inhibitor Market Share by 2031March 24, 2023 | marketwatch.comProton Pump Inhibitor Drug Market with Latest Technology Estimate up to 2030March 24, 2023 | marketwatch.comPAA Scale Inhibitor Market Top Players By 2031February 10, 2023 | finance.yahoo.comInhibitor Therapeutics, Inc. (INTI)January 31, 2023 | finance.yahoo.comAbbisko Therapeutics announces that US FDA has granted breakthrough therapy designation for its CSF-1R inhibitor Pimicotinib（ABSK021）January 29, 2023 | marketwatch.comQuince Therapeutics Shares Jump 65% After Sale of Protease Inhibitor PortfolioJanuary 27, 2023 | yahoo.comRakovina Therapeutics Announces Presentation at the 6th Annual DDR-inhibitors SummitJanuary 24, 2023 | marketwatch.comAnaplastic Lymphoma Kinase ALK Inhibitor Market Market Size 2023 Industry Analysis, Key Players, Regional Demand, Opportunity and Forecast 2028January 19, 2023 | benzinga.comNEW THERAPY TO TREAT RARE GASTROINTESTINAL STROMAL TUMOUR APPROVED FOR NEW ZEALAND PATIENTSAugust 26, 2022 | marketwatch.comWax Inhibitor Market 2022 Industry Size, Trends, Global Growth, Insights and Forecast Research Report 2028August 26, 2022 | markets.businessinsider.comInhibikase Says FDA Clears IND For IkT-001Pro To Treat Chronic Myelogenous LeukemiaAugust 26, 2022 | marketwatch.comKinase Inhibitor Market Growth Trends and Size Analysis 2022 Segment by Regions, Dynamics, Sales revenue and Industry Share Forecast to 2030August 19, 2022 | marketwatch.comVanadium Inhibitor Market Forecast With Trends, Challenges & Drivers & Top Key Players By 2029| Exclusive 104 Pages ReportAugust 16, 2022 | marketwatch.comEnzyme Inhibitor Market Share 2022 Global Business Growth, Industry Revenue, Demand and Applications Market Research Report to 2028August 12, 2022 | yahoo.comInhibikase Therapeutics Reports Second Quarter 2022 Financial Results and Highlights Recent Period ActivityAugust 10, 2022 | uk.finance.yahoo.comArtios initiates Phase 2 study of Polθ Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast CancerAugust 10, 2022 | tmcnet.comArtios initiates Phase 2 study of Pol? Inhibitor ART4215 in Combination with PARP Inhibitor Talazoparib in BRCA Deficient Breast CancerAugust 9, 2022 | marketwatch.comGlobal Immune Anti-Inhibitor Market 2022 Advance Technology, Latest Trend and Future Expansion by 2028August 8, 2022 | apnews.comeFFECTOR Therapeutics Appoints Douglas Warner, M.D., as Chief Medical OfficerAugust 7, 2022 | seekingalpha.comWeek In Review: Innovent Lands $305 Million Investment From Sanofi; Will Partner Two Candidates In ChinaAugust 4, 2022 | nz.finance.yahoo.comGlobal CD47 Inhibitor Drug Clinical Trials Insight 2028August 2, 2022 | marketwatch.comPickling Inhibitor Market Trends In 2022 : Growth, Size, Segmentation, Future Demands, Latest Innovation, Sales Revenue by Regional Forecast 2028 Get Inhibitor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for INTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Buy this small stock before coming AI Tidal Wave (Ad)The internet generated more wealth than any other innovation in history - creating hundreds of thousands of new millionaires in America alone. Now A.I. could do the same. But if you're buying Microsoft or NVIDIA to profit - you're missing the big picture. Get the name and ticker symbol for free - just click here. INTI Media Mentions By Week INTI Media SentimentLearn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. INTI News Sentiment▼-0.800.77▲Average Medical News Sentiment INTI News CoverageLearn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. INTI Articles This Week▼10▲INTI Articles Average Week Get Inhibitor Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for INTI and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: vTv Therapeutics News Today Annovis Bio News Today Landos Biopharma News Today Tempest Therapeutics News Today Aileron Therapeutics News Today Journey Medical News Today Sernova News Today Aclaris Therapeutics News Today BioXcel Therapeutics News Today Earth Science Tech News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:INTI) was last updated on 6/2/2024 by MarketBeat.com Staff From Our PartnersWrite this ticker symbol down…StocksToTradeTrump’s Gift Could Unleash $51 Billion in New WealthWealthpin ProBiden Nomination CANCELED?The Freeport SocietyBuy this small stock before coming AI Tidal WaveChaikin AnalyticsWarren Buffett, Jeff Bezos, Michael Bloomberg, & 48 Members of Congress Are Buying ONE Sector…InvestorPlaceExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersHe Is Giving Away BitcoinCrypto Swap ProfitsShocking $16T Elon Musk Crypto LeakCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Inhibitor Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
